Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H31NO3.ClH |
| Molecular Weight | 393.9481 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CC#CCOC(=O)[C@](c1ccccc1)(C2CCCCC2)O.Cl
InChI
InChIKey=SWIJYDAEGSIQPZ-FTBISJDPSA-N
InChI=1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H/t22-;/m0./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.4609 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C22H31NO3 |
| Molecular Weight | 357.4873 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A population pharmacokinetic model with time-dependent covariates measured with errors. | 2004 Jun |
|
| Rapid and selective UV spectrophotometric and RP-HPLC methods for dissolution studies of oxybutynin immediate-release and controlled-release formulations. | 2004 Nov 15 |
|
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005 Jun |
|
| Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. | 2005 Mar 21 |
|
| Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin. | 2007 Jul 13 |
|
| Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin. | 2008 Feb 2 |
|
| Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor. | 2008 May 15 |
|
| Reversible bilateral optic neuritis after Infliximab discontinuation in a patient with Crohn's disease. | 2009 Sep |
|
| Application of oxybutynin selective sensors for monitoring the dissolution profile and assay of pharmaceutical dosage forms. | 2010 |
|
| Medical management of overactive bladder. | 2010 Apr |
|
| Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence. | 2010 Sep 14 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 02:59:11 UTC 2021
by
admin
on
Sat Jun 26 02:59:11 UTC 2021
|
| Record UNII |
JWB87T68BN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
11349918
Created by
admin on Sat Jun 26 02:59:11 UTC 2021 , Edited by admin on Sat Jun 26 02:59:11 UTC 2021
|
PRIMARY | |||
|
JWB87T68BN
Created by
admin on Sat Jun 26 02:59:11 UTC 2021 , Edited by admin on Sat Jun 26 02:59:11 UTC 2021
|
PRIMARY | |||
|
1207344-05-5
Created by
admin on Sat Jun 26 02:59:11 UTC 2021 , Edited by admin on Sat Jun 26 02:59:11 UTC 2021
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER |
